Clinical Trial Update: Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas [Phase 2]

View source ↗

Summary

Clinical trial update reporting completion of a Phase 2 pilot protocol for the treatment of Burkitt lymphoma and diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burkitt Lymphoma
• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Burkitt Lymphoma, Lymphoma, Large-Cell, Diffuse | Phase 2 | Status: COMPLETED